<div id="readability-page-1"><p>Wells Fargo analyst Mohit Bansal maintained a Buy rating on Vertex Pharmaceuticals yesterday and set a price target of $515.00.</p><h3>TipRanks Cyber Monday Sale</h3><ul><li> Claim 60% off TipRanks Premium  for data-backed insights and research tools you need to invest with confidence.  </li><li>  Subscribe to TipRanks' Smart Investor Picks  and see our data in action through our high-performing model portfolio - <u> now also 60% off </u></li></ul> <p>Bansal covers the Healthcare sector, focusing on stocks such as Regeneron, Gilead Sciences, and Amgen. According to TipRanks, Bansal has an average return of <span>11.4%</span> and a 59.06% success rate on recommended stocks. </p> <p>In a report released on December 8, Scotiabank also maintained a Buy rating on the stock with a $495.00 price target.</p></div>

VRTX

<p>Wells Fargo analyst Mohit Bansal maintained a Buy rating on Vertex Pharmaceuticals with a $515 price target. Scotiabank also kept a Buy rating with a $495 target. Bansal, focusing on healthcare stocks, has an average return of 11.4% and a 59.06% success rate. TipRanks offers a Cyber Monday sale for investment tools.</p>

Vertex Pharmaceuticals (VRTX) Receives a Buy from Wells Fargo